400 is a magic number for Dendreon investors. It's the level of annualized Provenge sales, in millions, that the company projects will allow them to achieve profitability. However, with today's preliminary fourth-quarter results showing only mid-single-digit growth, progress toward that goal is painstakingly slow. In the following video, Brenton discusses the release in more detail.
